ALUR ALLURION TECHNOLOGIES, INC.

NYSE


$ 1.43 $ 0.00 (0 %)    

Thursday, 13-Nov-2025 08:39:44 EST
QQQ $ 617.40 $ 0.00 (0 %)
DIA $ 481.61 $ 0.00 (0 %)
SPY $ 680.52 $ 0.00 (0 %)
TLT $ 89.86 $ 0.00 (0 %)
GLD $ 388.14 $ 0.00 (0 %)
$ 1.5
$ 1.50
$ 1.41 x 100
$ 1.52 x 100
-- - --
$ 1.35 - $ 17.50
273,242
na
96.73M
$ 2.90
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-19-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-26-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 10-20-2023 06-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 allurion-technologies-q3-adj-eps-118-misses-117-estimate-sales-2658m-beat-2350m-estimate

Allurion Technologies (NYSE:ALUR) reported quarterly losses of $(1.18) per share which missed the analyst consensus estimate of...

 allurion-technologies-passes-critical-milestones-in-us-fdas-pre-market-approval-process-for-allurion-smart-capsule-company-to-exchange-all-outstanding-debt-obligations-for-shares-of-newly-created-series-b-convertible-preferred-stock

Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a pioneer in metabolically healthy weig...

 allurion-highlights-peer-reviewed-publication-on-consecutive-use-of-allurion-smart-capsule

Multicenter study across six countries demonstrates safety and efficacy of two consecutive treatments in adults with obesityWei...

 watching-allurion-technologies-shares-see-volume-to-the-upside-traders-circulate-x-post-saying-new-publication-in-the-obesity-surgery-journal-about-the-allurion-swallowable-gastric-balloon-program-titled-weight-loss-maintenance-1-year-after-the-swallowable-gastric-balloon-results-from-an-international-multicenter-study

https://link.springer.com/article/10.1007/s11695-025-08074-2

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION